Pharmacokinetics of emedastine dtfumarate, a new anti-histaminic agent in patients with renal impairment

European Journal of Clinical Pharmacology

Volumn 56, Issue 12, 2001, Pages 905-910

  Joukhadar, Christian ^a   Herranz, Ursula ^b   Pernerstorfer, Thomas ^a   Assandri, Alessandro ^b   Klein, Nikolas ^a   Schrolnberger, Claudia ^a   Lackner, Edith ^a   Eichler, Hans G ^a   Müller, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Cross Research SA   (Switzerland)

Author keywords

Emedastine; Pharmacokinetics; Tolerability

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; EMEDASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADULT; AREA UNDER THE CURVE; CLINICAL TRIAL; FEMALE; HALF LIFE TIME; HUMAN; KIDNEY FAILURE; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BENZIMIDAZOLES; FEMALE; HALF-LIFE; HISTAMINE H1 ANTAGONISTS; HUMANS; LINEAR MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RENAL INSUFFICIENCY;

EID: 0034464809     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000256     Document Type: Article

References (21)

1. Simons EF, Simons KJ (1994) The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 330:1663-1670
2. Fukuda T, Saito T, Tajima S, Shimohara K, Ito K (1984) Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413). Arzneimittelforschung 34:805-810
3. Fukuda T, Saito T, Yoshidomi M, Ito K (1984) Influence of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413). a new antiallergic, on ciliary movement. Arzneimittelforschung 34:816-818
4. Fukuda T, Saito T, Ito K (1984) Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1 homopiperazinyl) benzimidazole difumarate (KB-2413). a new antiallergic. Arzneimittelforschung 34:811-815
5. Fukuda T, Morimoto Y, Lemura R, Kawashima T, Tsukamoto G, Ito K (1984) Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate (KB-2413), a new antiallergic, on chemical mediators. Arzneimittelforschung 34:801-805
6. Fleisch JH, Rinkema LE, Haisch KD, Whitesitt CA (1987) Pharmacologic analysis of LY188695 (KB-2413). 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate. a potent histamine 1 receptor antagonist. Agents Actions 20:40-49
7. Silbaugh SA, Stengel PW, Rinkema LE (1987) Pulmonary aerosol actions of LY188695 (KB2413), a new potent H1-receptor antagonist. Agents Actions 21:83-88
8. Inagaki N, Sakurai T, Abe T, Musoh K, Kawasaki H, Tsunematsu M, Nagai H (1998) Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. Life Sci 63:145-150
9. Jansen B, Graselli U, Dallinger S, Kiss B, Wachek V, Schlaglbauer-Wadl H, Assandri A, Müller M (2000) Pharmacokinetics and pharmacodynamics of a novel H1-receptor antagonist emedastine in healthy volunteers. Eur J Clin Pharmacol 55:837-841
10. Saito T, Fukuda T, Tajima S, Sukamoto T, Yamashita A, Kanazawa T, Morimoto Y, Shimohara K, Nishimura N, Yokota K, et al (1988) General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate. 2nd communication: effects on the circulation and the other systems. Arzneimittelforschung 38:267-272
11. Saito T, Fukuda T, Sukamoto T, Yoshidomi M, Morimoto Y, Shimohara K, Ito K (1988) General pharmacology of 1-(2-ethoxyelhyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate. 1st communication: effects on the central nervous system. Arzneimittelforschung 38:66-69
12. Hamada T, Kadowaki M, Awata N (1987) Radioreceptor assay for a new antiallergic agent. 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413), in plasma. Chem Pharm Bull (Tokyo) 35:3329-3335
13. Simons FR, Simons KJ, Chung M, Yeh J (1987) the comparative pharmacokinetics of H1-receptor antagonists. Ann Allergy 59:20-24
14. Matzke GR, Yeh J, Awni WM, Halstenson CE, Chung M (1987) Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy 59:25-30
15. Ishida M, Iwamoto S, Sakamoto F (1997) Identification of human P450 isoforms involved in the metabolism of emedastine difumarate. Kiso to Rinsho 31:3089-3093
16. Amada T, Awata N (1990) Metabolism of a new antiallergic agent, emedastine difumarate in human. Xenobio Met Dispos 5:871-881
17. Buraglio M (1995) Emedastine difumarate - tolerability and pharmacokinetics in male healthy volunteers after administration of 4 single ascending doses from 1 to 8 mg by oral route. RBM experiment No. 950224 [Institute di Ricerche Biomediche Antoine Marxer RBM Sp. A., P.O. Box 226, 10015 Ivrea (To), Italy]
18. Wrington SA, Stevens JC (1992) The human hepatic cytochrome P-450 involved in drug metabolism. Crit Rev Toxicol 22:1-21
19. Harrower AD (1996) Pharmacokinetics of oral antihyperglycemic agents in patients with renal insufficiency. Clin Pharmacokinet 31:111-119
20. Lam YW, Banerji S, Hatfield C, Talbert RL (1997) Principles of drug administration in renal insufficiency. Clin Pharmacokinet 32:30-57
21. 14C emedastine difumarate in male healthy volunteers administered as a single oral dose. Vienna University Medical School, Vienna